Kazlow, E.; Rinawi, E.; Gerszman, E.; Mattar, S.; Essami, N.; Nasir, M.; Abu Shtaya, A.; Assaf, W.; Haddad, R.; Mahamid, A.
Higher Neutrophil-to-Lymphocyte Ratio and Systemic Immune–Inflammation Index Is Associated with Better Prognosis Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma. J. Clin. Med. 2025, 14, 3762.
https://doi.org/10.3390/jcm14113762
AMA Style
Kazlow E, Rinawi E, Gerszman E, Mattar S, Essami N, Nasir M, Abu Shtaya A, Assaf W, Haddad R, Mahamid A.
Higher Neutrophil-to-Lymphocyte Ratio and Systemic Immune–Inflammation Index Is Associated with Better Prognosis Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma. Journal of Clinical Medicine. 2025; 14(11):3762.
https://doi.org/10.3390/jcm14113762
Chicago/Turabian Style
Kazlow, Esther, Elias Rinawi, Eden Gerszman, Samar Mattar, Nabih Essami, Mary Nasir, Aasem Abu Shtaya, Wisam Assaf, Riad Haddad, and Ahmad Mahamid.
2025. "Higher Neutrophil-to-Lymphocyte Ratio and Systemic Immune–Inflammation Index Is Associated with Better Prognosis Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma" Journal of Clinical Medicine 14, no. 11: 3762.
https://doi.org/10.3390/jcm14113762
APA Style
Kazlow, E., Rinawi, E., Gerszman, E., Mattar, S., Essami, N., Nasir, M., Abu Shtaya, A., Assaf, W., Haddad, R., & Mahamid, A.
(2025). Higher Neutrophil-to-Lymphocyte Ratio and Systemic Immune–Inflammation Index Is Associated with Better Prognosis Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma. Journal of Clinical Medicine, 14(11), 3762.
https://doi.org/10.3390/jcm14113762
